Ronna Romney Sells 700 Shares of Molina Healthcare, Inc (NYSE:MOH) Stock

Key Points

• Ronna Romney, a director at Molina Healthcare, sold 700 shares at an average price of $153.74, reducing her ownership to 17,131 shares valued at approximately $2.6 million.
• Molina Healthcare's stock is currently valued at $156.87, reflecting a 1.2% increase during recent trading sessions, despite missing earnings estimates for the last quarter.
• Recent analyst reports have downgraded Molina Healthcare's target prices significantly, with Barclays lowering it from $270 to $186, indicating mixed sentiments among market analysts.

Molina Healthcare, Inc (NYSE:MOH - Get Free Report) Director Ronna Romney sold 700 shares of the firm's stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total transaction of $107,618.00. Following the completion of the sale, the director owned 17,131 shares of the company's stock, valued at $2,633,719.94. This trade represents a 3.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Molina Healthcare Price Performance

MOH traded up $1.38 during midday trading on Tuesday, reaching $155.21. 424,423 shares of the company's stock were exchanged, compared to its average volume of 958,815. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.66 and a quick ratio of 1.66. The stock has a market capitalization of $8.41 billion, a PE ratio of 7.65 and a beta of 0.52. The business's 50-day moving average price is $233.88 and its 200 day moving average price is $285.70. Molina Healthcare, Inc has a 1-year low of $151.95 and a 1-year high of $365.23.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). The business had revenue of $11.43 billion for the quarter, compared to analyst estimates of $10.94 billion. Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%. The business's revenue was up 15.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $5.86 EPS. As a group, equities analysts anticipate that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.

Hedge Funds Weigh In On Molina Healthcare

Institutional investors have recently modified their holdings of the company. Price T Rowe Associates Inc. MD increased its position in Molina Healthcare by 46.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company's stock worth $1,264,214,000 after purchasing an additional 1,216,903 shares during the last quarter. T. Rowe Price Investment Management Inc. increased its position in Molina Healthcare by 8.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 1,487,896 shares of the company's stock worth $490,099,000 after purchasing an additional 117,796 shares during the last quarter. Invesco Ltd. increased its position in Molina Healthcare by 28.5% during the fourth quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock worth $386,229,000 after purchasing an additional 294,180 shares during the last quarter. AQR Capital Management LLC increased its position in Molina Healthcare by 42.7% during the first quarter. AQR Capital Management LLC now owns 884,958 shares of the company's stock worth $288,125,000 after purchasing an additional 264,664 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its position in Molina Healthcare by 15.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 688,245 shares of the company's stock worth $200,307,000 after purchasing an additional 91,229 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company's stock.

Analyst Ratings Changes

MOH has been the subject of several recent analyst reports. Wall Street Zen cut shares of Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, June 29th. Truist Financial reiterated a "hold" rating and issued a $180.00 price target (down previously from $335.00) on shares of Molina Healthcare in a report on Friday, July 25th. Cantor Fitzgerald reiterated a "neutral" rating and issued a $210.00 price target (down previously from $312.00) on shares of Molina Healthcare in a report on Friday, July 25th. Morgan Stanley downgraded shares of Molina Healthcare from an "overweight" rating to an "equal weight" rating and cut their price target for the company from $364.00 to $266.00 in a report on Thursday, July 10th. Finally, Wells Fargo & Company cut their price target on shares of Molina Healthcare from $372.00 to $216.00 and set an "overweight" rating for the company in a report on Wednesday, July 23rd. Eleven investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $244.55.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.